# A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir

> **NCT05155007** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rilematovir
- **DRUG:** Ciclosporin

## Key facts

- **NCT ID:** NCT05155007
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-10
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155007, "A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05155007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*